4//SEC Filing
Benaim Ely 4
Accession 0001645113-22-000073
CIK 0001645113other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:32 PM ET
Size
6.1 KB
Accession
0001645113-22-000073
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Benaim Ely
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
2022-08-03$74.00/sh−5,396$399,304→ 28,672 total - Sale
Ordinary Shares
2022-08-03$71.09/sh−563$40,024→ 34,068 total
Footnotes (1)
- [F1]Transaction was made pursuant to a Rule 10b-5-1 trading plan adopted by Dr. Benaim.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001632237
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:32 PM ET
- Size
- 6.1 KB